Navigation Links
Omeros Submits OMS302 Marketing Authorization Application to European Medicines Agency
Date:9/10/2013

SEATTLE, Sept. 10, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that it recently submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) seeking approval to market OMS302 for use in patients undergoing intraocular lens replacement (ILR) surgery in the European Union (EU). Added to standard irrigation solution used during ILR, OMS302 is Omeros' proprietary PharmacoSurgery® product that, across multiple human trials, demonstrated clinically meaningful and statistically significant maintenance of intraoperative mydriasis (pupil dilation), prevention of intraoperative miosis (pupil constriction), and reduction of postoperative ocular pain.

With the submission by Omeros of a New Drug Application (NDA) for OMS302 to the U.S. Food and Drug Administration (FDA) in July 2013, the MAA represents Omeros' second major submission seeking regulatory authorization to market OMS302. The EMA previously granted OMS302 eligibility for centralized review, determining that the product represents a significant therapeutic innovation. The MAA for OMS302, therefore, was submitted through EMA's Centralized Procedure, which allows submission of a single application that, when approved, authorizes the drug to be marketed in all EU member states and European Free Trade Association countries rather than requiring separate national approvals. The NDA and MAA are each subject to an initial evaluation prior to commencement of the formal review process. Assuming successful completion of the review process and approval of the NDA and MAA, OMS302 is expected to be available to ophthalmic surgeons and their patients in the U.S. and Europe in the second half of 2014.

"Having submitted two major marketing applications just weeks apart for our lead product is an outstanding achievement," said Gregory A. Demopulos, M.D., chairman a
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omeros to Present at Deutsche Bank Securities Health Care Conference
2. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
3. Omeros to Present at Jefferies 2012 Global Healthcare Conference
4. Omeros Announces Proposed Public Offering of Common Stock
5. Omeros Prices $30 Million Public Offering of Common Stock
6. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Omeros Announces Discovery in MASP-2 Program
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
11. Omeros to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... --  Vittamed Corporation , a neurodiagnostics medical device company based ... T. (Teo) Forcht Dagi , MD, DmedSc, MPH, MBA, FACS, ... " Teo Forcht Dagi is an experienced ... venture capital," said Remis Bistras , President and CEO ... strategic, and entrepreneurial expertise to our Board." Dr. ...
(Date:8/29/2014)... Research and Markets has announced ... Market 2014-2018" report to their offering. ... that results in demyelination, axonal transection, and neurodegeneration. The ... by the immune system, which targets neurons within the ... disease in which the damage of the myelin sheath ...
(Date:8/29/2014)... -- Pixcelldata, the innovative Irish developer of ... major new deal with Dutch based eX-Path, global providers ... Marius Nap . The announcement was ... Pathology which is taking placing between August 30th and ... where Pixcelldata will demonstrate its innovative solution. ...
Breaking Medicine Technology:Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2
(Date:8/30/2014)... According to the latest review on DailyGossip.org, this is ... skin health. It seems that the method is so popular ... 138,000 patients from all over the world. , The ... method will not only eliminate acne forever, but will also ... this program unique among other methods of curing candida is ...
(Date:8/30/2014)... Capital Region, NY (PRWEB) August 31, 2014 ... the largest and fastest growing union in New York ... bringing good, middle-class healthcare jobs and the best quality ... regions. , In recent years, thousands of healthcare ... for themselves and their families by becoming members of ...
(Date:8/30/2014)... UWDress.com, a distinguished wedding dress supplier, has gained ... of fashionable outfits. Recently, the company has unveiled its beautiful ... autumn special offer, all these brand new products are provided ... “We are excited to unveil the new and trendy bridesmaid ... products are available at low prices now. The purpose of ...
(Date:8/30/2014)... San Diego, CA (PRWEB) August 30, 2014 ... Rebecca Doherty upheld a decision that requires Takeda Pharmaceutical ... billion in punitive damages for claims that the drugmakers ... with the diabetes medication Actos. The case, Allen v. ... the U.S. District Court, Western District of Louisiana (Lafayette).* ...
(Date:8/30/2014)... United Theological Seminary is pleased to announce the launch ... Theological Studies (MTS). , This degree, which ... who wish to pursue further academic study of religion (Ph.D.) ... Church and community. Previously, students needed to be on campus ... from any location where there is an internet connection. ...
Breaking Medicine News(10 mins):Health News:Acne No More Review Reveals Unusual Tip to Eliminate Acne Permanently 2Health News:This Labor Day, 1199SEIU Continues Commitment to Growing Local Economies with Good, Middle-Class Healthcare Jobs 2Health News:This Labor Day, 1199SEIU Continues Commitment to Growing Local Economies with Good, Middle-Class Healthcare Jobs 3Health News:This Labor Day, 1199SEIU Continues Commitment to Growing Local Economies with Good, Middle-Class Healthcare Jobs 4Health News:UWDress.com’s Beautiful Collection Of “Flowy Bridesmaid Dresses” Released 2Health News:The Law Office of Melinda J. Helbock A.P.C. Comments on Decision to Uphold $9 Billion Actos Award 2Health News:United Theological Seminary Announces First Fully Online Degree 2
... GUANGZHOU, China, July 17 /Xinhua-PRNewswire/ -- China ... or "the Company"),a leading distributor and developer ... (TCMs), nutritional and dietary supplements,medical devices, and ... China,(PRC), announced today that it obtained a ...
... 17 Fresh Harvest Products,Inc. (OTC Bulletin Board: ... its long standing commitment to providing consumers with ... new initiative to,build natural and organic brands and ... Harvest brands,through our network., "We believe that ...
... /Xinhua-PRNewswire-FirstCall/ -- Mindray,Medical International Limited (NYSE: MR ... devices worldwide has announced today that it will,highlight ... well as,unveil three new units and reagents at ... conference. The conference will be attended,by Mr. Jie ...
... Calif., July 17 Cardica, Inc.,(Nasdaq: CRDC ... to the,position of vice president, operations. Mr. Bauer ... operations and manufacturing experience to,Cardica from large healthcare ... operations experience and his continuous drive to,improve quality ...
... 2, 2009 -, LAVAL, QC, July 17 /PRNewswire-FirstCall/ ... the response that it submitted to the,U.S. Food and ... analysis of existing data as suggested by the Agency, ... action date assigned by the,FDA under the Prescription Drug ...
... Ceremonies for the 23rd Annual Great Sports,Legends Dinner to Benefit The Buoniconti ... ... NEW YORK, July 17 Sports luminaries and philanthropy,icons will be recognized ... September 22, at New York,s Waldorf=Astoria,Hotel. This year, Bob Costas has been ...
Cached Medicine News:Health News:China Medicine Corporation Obtains Australian Patent for rADTZ 2Health News:China Medicine Corporation Obtains Australian Patent for rADTZ 3Health News:Fresh Harvest Products, Inc. Announces New Brand Initiative 2Health News:Mindray to Unveil Three New Products and Reagents at AACC Annual Meeting 2Health News:Mindray to Unveil Three New Products and Reagents at AACC Annual Meeting 3Health News:Cardica Names Frederick Bauer Vice President of Operations 2Health News:Cardica Names Frederick Bauer Vice President of Operations 3Health News:FDA accepts Labopharm's response for once-daily tramadol as complete Class 2 response 2Health News:Sports Luminaries Andre Agassi, Jerry Rice, Scottie Pippen, Helio Castrovenes, Richard 'Goose' Gossage Among Those Named 2008 'Great Sports Legends' 2Health News:Sports Luminaries Andre Agassi, Jerry Rice, Scottie Pippen, Helio Castrovenes, Richard 'Goose' Gossage Among Those Named 2008 'Great Sports Legends' 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: